Quantitative Multi-Parametric MRI of the Prostate Reveals Racial Differences
- PMID: 39456593
- PMCID: PMC11505680
- DOI: 10.3390/cancers16203499
Quantitative Multi-Parametric MRI of the Prostate Reveals Racial Differences
Abstract
Purpose: This study investigates whether quantitative MRI and histology of the prostate reveal differences between races, specifically African Americans (AAs) and Caucasian Americans (CAs), that can affect diagnosis. Materials and Methods: Patients (98 CAs, 47 AAs) with known or suspected prostate cancer (PCa) underwent 3T MRI (T2W, DWI, and DCE-MRI) prior to biopsy or prostatectomy. Quantitative mpMRI metrics: ADC, T2, and DCE empirical mathematical model parameters were calculated. Results: AAs had a greater percentage of higher Gleason-grade lesions compared to CAs. There were no significant differences in the quantitative ADC and T2 values between AAs and CAs. The cancer signal enhancement rate (α) on DCE-MRI was significantly higher for AAs compared to CAs (AAs: 13.3 ± 9.3 vs. CAs: 6.1 ± 4.7 s-1, p < 0.001). The DCE signal washout rate (β) was significantly lower in benign tissue of AAs (AAs: 0.01 ± 0.09 s-1 vs. CAs: 0.07 ± 0.07 s-1, p < 0.001) and significantly elevated in cancer tissue in AAs (AAs: 0.12 ± 0.07 s-1 vs. CAs: 0.07 ± 0.08 s-1, p = 0.02). DCE significantly improves the differentiation of PCa from benign in AAs (α: 52%, β: 62% more effective in AAs compared to CAs). Histologic analysis showed cancers have a greater proportion (p = 0.04) of epithelium (50.9 ± 12.3 vs. 44.7 ± 12.8%) and lower lumen (10.5 ± 6.9 vs. 16.2 ± 6.8%) in CAs compared to AAs. Conclusions: This study shows that AAs have different quantitative DCE-MRI values for benign prostate and prostate cancer and different histologic makeup in PCa compared to CAs. Quantitative DCE-MRI can significantly improve the performance of MRI for PCa diagnosis in African Americans but is much less effective for Caucasian Americans.
Keywords: African Americans; Caucasian Americans; DCE-MRI; MRI; prostate cancer; quantitative; racial differences.
Conflict of interest statement
The authors state that they have no conflicts of interest related to the material discussed in this article. Drs. Chatterjee, Oto, and Karczmar have equity in QMIS, LLC, which is unrelated to this study.
Figures


Similar articles
-
The Role of Dynamic Contrast Enhanced Magnetic Resonance Imaging in Evaluating Prostate Adenocarcinoma: A Partially-Blinded Retrospective Study of a Prostatectomy Patient Cohort With Whole Gland Histopathology Correlation and Application of PI-RADS or TNM Staging.Prostate. 2025 Apr;85(5):413-423. doi: 10.1002/pros.24843. Epub 2024 Dec 19. Prostate. 2025. PMID: 39702937 Free PMC article.
-
Enhancing the diagnostic capacity of [18F]PSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory study.EJNMMI Rep. 2024 Nov 8;8(1):37. doi: 10.1186/s41824-024-00225-5. EJNMMI Rep. 2024. PMID: 39510993 Free PMC article.
-
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation.Health Technol Assess. 2013 May;17(20):vii-xix, 1-281. doi: 10.3310/hta17200. Health Technol Assess. 2013. PMID: 23697373 Free PMC article.
-
Performance of apparent diffusion coefficient values and ratios for the prediction of prostate cancer aggressiveness across different MRI acquisition settings.Diagn Interv Radiol. 2022 Jan;28(1):12-20. doi: 10.5152/dir.2022.20732. Diagn Interv Radiol. 2022. PMID: 35142611 Free PMC article.
-
MRI software and cognitive fusion biopsies in people with suspected prostate cancer: a systematic review, network meta-analysis and cost-effectiveness analysis.Health Technol Assess. 2024 Oct;28(61):1-310. doi: 10.3310/PLFG4210. Health Technol Assess. 2024. PMID: 39367754 Free PMC article.
Cited by
-
Negative Predictive Value of a Prostate MRI in Black Men: Implications for Biopsy Decision-Making.J Urol. 2025 Jun;213(6):713-721. doi: 10.1097/JU.0000000000004498. Epub 2025 Mar 17. J Urol. 2025. PMID: 40096657
-
The United States Preventive Services Task Force (USPSTF) Guidelines vs. Electronic Health Record (EHR)-Based Screening: A Comparative Accuracy Study in Prostate Cancer.Cureus. 2025 Jul 27;17(7):e88863. doi: 10.7759/cureus.88863. eCollection 2025 Jul. Cureus. 2025. PMID: 40881554 Free PMC article.
References
-
- American Cancer Society Key Statistics for Prostate Cancer. [(accessed on 9 April 2024)]. Available online: https://www.cancer.org/cancer/types/prostate-cancer/about/key-statistics....
Grants and funding
LinkOut - more resources
Full Text Sources